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An Interprofessional Approach to Train Medical Students & Respiratory Therapy Students 
in Basic Principles of Mechanical Ventilation  
 
Mary Jo S. Farmer, MD, PhD Baystate Medical Center Springfield, MA 
 
PROFESSIONAL EXPECTATION 
Care of the mechanically ill ventilated critically patient in the Medical ICU is 
accomplished by a team of health care professionals 
Optimum communication between the physician and respiratory therapist is 
essential in providing mechanical ventilator support 
A professional working relationship includes mutual respect and 
understanding of the roles and responsibilities of each discipline of the health 
care team 
GOALS 
Promote knowledge regarding mechanical ventilation including ABG 
 analysis, modes of mechanical ventilation, ventilator settings,  
basic waveform analysis. 
Providing opportunity for interprofessional interaction at the student  
level will ease transition to health care team model at the professional level 
 
IMPLEMENTATION 
• 2 groups (group 1 7MD/7RT; group 2 8MD/7RT)  
• Common components: 
• 4 week sessions – 2.5 hours 
• Pre-test (9 core material; 6 opinion; 2 open-ended) 
• Post-test 
• Focus group 
• Differences: 
• Group 1 (7MD/7RT)   
• Traditional lectures on ABG analysis   
• modes of mechanical ventilation and waveform analysis including 
problem solving 
• small group MICU bedside 
• Group 2 (8 MD/7RT) 
• Independent reading 
• Small intentionally mixed groups 
• Independent case problem solving 
• Bedside ICU 
FOCUS GROUP 1 
Exposure to attending MD valuable 
MICU great experience 
Why 3rd year 
Shelf exam 
Intimidation 
Assumed difference in knowledge level 
MS versus RT - proficient in waveforms 
FOCUS GOUP1 (CONT’D) 
Lectures beneficial - more hands on 
More time with patients 
Less didactic and more group problem solving 
Vocabulary (PEEP, DKA) 
Not enough time to master material 
Limited opportunity to know other students 
Provide snacks 
 
FOCUS GROUP 2 
Working with different professionals very valuable 
Learn roles 
Work alongside other students to take better care of patients 
ABGs, specifically how to use ventilator to turn ABG around 
Approach a patient on a ventilator 
Learning to feel confident when stating my opinion about what would be best 
for patient and why 
Does what we learn in medical school correlate with what other professionals 
are taught in regards to approaching a patient with a respiratory problem 
What does the MD need to know to manage ICU patients 
When to call RT and involve in decision making process 
Lots of clinical examples and clinical problems  
How to set the ventilator and manipulate settings 
Simulation laboratory 
Reading material – not being tested 
 
RESULTS 
Core questions (9) 
• Group 1 (7MD/7RT) 
• Pre-test  
• Respiratory (11) + Medical (20) = 31 
• Post-test 
• Respiratory (35) + Medical (27) = 62 
• Group 2 (8MD/7RT) 
• Pre-test  
• Respiratory (16) + Medical (23) = 41 
• Post-test 




 RESULTS (CONT’D 
Valuable to train alongside students of other disciplines in the classroom (Y/N) 
• Group 1  
• Pre-test: 1 MS “depends”; others “yes” 
• Post-test: 2 MS “no” 
• Group 2 
• Pre-test: all “yes” 
• Post-test: 1 MS “no”; others “yes” 
Valuable to train alongside students of other disciplines in clinical setting 
(Y/N) 
• Group 1  
• Pre-test: 1 MS “depends”; others “yes” 
• Post-test: 1 MS “no” 
• Group 2 
• Pre-test: all “yes” 
• Post-test: all “yes” 
Topic least knowledgeable 
• Group 1  
• Pre-test: 10 waveform analysis; 2 weaning 
• Post-test: 8 weaning; 5 waveform analysis 
• Group 2 
• Pre-test: 10 waveform analysis; 4 weaning 
• Post-test: 7 waveform analysis; 5 weaning 
Topic most knowledgeable 
• Group 1  
• Pre-test: 14 arterial blood gas analysis 
• Post-test: 13 arterial blood gas analysis 
• Group 2 
• Pre-test: 14 ABG analysis; 1 initiating MV 
• Post-test: 11 ABG analysis; 3 initiating MV 
 
LESSONS LEARNED 
• Chemistry within group is crucial 
• Expectations 
• Seating 
• Introduction and ice breaker 
• Comfort level – timing in clinical year “clinical savvy” 
• One of me 




Tufts University School of Medicine Innovations in Education Grant 
Dr. Michael Picchioni, TUSM IM Core Clerkship Director, Baystate Medical Center;  Ester Perrelli, Director of Clinical Rotations, 
Springfield Technical Community College;  Reva Kleppel, Academic Affairs, Baystate Medical Center  
An Observational Study on the Management Practices of Postoperative New 
Onset Atrial Fibrillation in Non-cardiothoracic Surgeries at a Tertiary Care 
Center  
Kanval Shah, MD; Anis John Kadado, MD; Mihaela Tiru, MD; Vida Rastegar, MPH;  
Kirti K Joshi, MD; Peter Lindenauer, MD, MSc; Tara Lagu, MD; Mihaela S Stefan, MD, PhD 
BACKGROUND 
• Postoperative atrial fibrillation (POAF) is the most common 
perioperative arrhythmia and it’s incidence in non-
cardiothoracic surgery varies from 0.4% to 26%.  
 
• POAF was considered to be self-limited and to have a favorable 
prognosis, but recent data has linked it to increased in-hospital 
mortality, length of stay, hospital costs and  risk of stroke. 
 
• There are no specific guidelines for the management of these 
patients. 
 
• Objective: To characterize in-hospital diagnostic testing, 
medical treatments and discharge recommendations in order to 
inform future practice guidelines and need for further research. 
• During the 6 years of the study ,99 patients were identified with 
new onset POAF  
• Patient characteristics: The median age was 75 years and 57.6% 
were male, with hypertension (66.7%) and diabetes mellitus 
(30.3%) being the most common comorbidities.  
• 28.3%  of the patients underwent colorectal surgery, 14.1% 
orthopedic surgeries, 14.1% vascular surgeries and 29.0% had 
trauma, hepatobiliary, genitourinary and neurosurgery 
procedures. 
• Consults were called in 74% of the cases 
• Short term outcomes:  Median length of hospitalization  was  9 








• There was significant practice variation between providers in 
the choice of strategies for short and long-term management 
of patients with POAF.  
• Most patients were asymptomatic but their outcomes were 
not different from the symptomatic patients raising questions 
about appropriate cardiac monitoring of surgical patients.  
• Risk scores to identify patients at high risk for POAF are 
urgently needed.  
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• Retrospective, single-center cohort study of adult patients who 
underwent non-cardiothoracic surgery and developed new 
onset POAF. 
Figure 1-Flow chart representing study screening, selection process 
and outcomes 
Figure 2- Flowchart depicting management strategies  
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• Anticoagulation was prescribed in 25% of the patients during 
hospitalization and in half of those discharged in AF. The 
CHADS2-VASc score and the HAS-BLED score did not correlate 
with the prescription of anticoagulation on discharge. 
• Long term outcomes:  30% were readmitted and half of them 
were in AF at the time of admission 
 
Figure 3- Graph showing consults obtained based on type of 
surgery  
HIV Clinicians’ Intention to Prescribe Buprenorphine and Naloxone:  
Baseline Results from the PTSL study 
Eric Romo BA; Donna Wilson MS; Alexander Y. Walley MD, MSc; Josiah D. Rich MD, MPH; Traci C. Green PhD, MSc; Susan E. Ramsey PhD; 
Jeffrey Bratberg PharmD; Michelle McKenzie MPH; Randall Hoskinson, Jr BS; Haley Guhn-Knight BA; & Peter D. Friedmann MD, MPH 
University of Massachusetts Medical School – Baystate 
Contact Information: 
Eric Romo | Eric.Romo@baystatehealth.org 
Results Conclusion Background 
Objective 
Methods 
Overview of the Prescribe To Save Lives study • To identify factors associated with HIV prescribers’ intention 
to prescribe buprenorphine and naloxone.  
• The use of opioids is common among persons living with HIV 
(PLWH), resulting in high rates of opioid overdose among PLWH. 
• Office-based buprenorphine treatment has been shown to reduce 
overdose mortality, and naloxone is an effective opioid reversal 
agent. 
• Despite this, HIV clinicians have been reluctant to adopt office-
based buprenorphine treatment and naloxone prescribing. 
Data Source 
• These are baseline data from the Prescribe to Save Lives 
(PTSL) study. 
Study Sample  
• 119 prescribers (physicians, advanced practitioners) from 
23 HIV outpatient practices across 18 states. 
• Inclusion criteria for HIV practices were that they: (1) 
receive Ryan White funding; (2) treat adults with HIV; (3) 
have 3 or more prescribing clinicians; (4) have an EMR with 
an electronic medication list; (5) are located in a state in the 
top half nationally for opioid overdose deaths; (6) are 
located in a state that has 500 or more PLWH. 
Outcome Measure 
• Prescribers reported intention to prescribe buprenorphine 
and naloxone: “How likely are you to prescribe 
[medication]?” 
• 5-point Likert scale, from (1) Not at all likely to (5) Very 
much so likely. 
• Intention to prescribe treated as a continuous variable 
Potential Correlates  
• Prescribers’ demographics, substance use assessment 
practices, addiction training, attitudes and knowledge 
towards buprenorphine and naloxone, and the substance 
use characteristics of their patient panel  
• These factors were assessed in the baseline survey 
Statistical Analysis 
• Mixed-effects linear regression models to identify factors 
associated with intention to prescribe buprenorphine and 
naloxone.  
• Account for the nested structure of the data (prescribers 
in practices) 
• HIV prescribers’ intention to prescribe buprenorphine and naloxone 
was associated with previous training and knowledge of these 
medications and greater self-efficacy.  
• Training and mentoring interventions, like that underway in the 
PTSL study, have the potential to increase uptake of office-based 
buprenorphine treatment and naloxone prescribing among HIV 
clinicians  
Table 1. Characteristics of HIV Prescribers (N=119) 
Characteristics % or mean (sd) 
Demographics   
Female 72% 
Age (years) 43 (10) 
White (vs. non-White) 62% 
Profession   
Physician 49% 
Nurse Practitioner 42% 
Physician Assistant 8% 
Intention to Prescribe   
Buprenorphine (1 to 5 scale) 2.9 (1.5) 
Naloxone (1 to 5 scale) 3.3 (1.4) 
Table 2. Mixed-Effects Linear  Models: Factors Associated with Intention 
to Prescribe Buprenorphine and Naloxone 
  Buprenorphine Naloxone 
Variable Beta Std. Error p-value   Beta Std. Error p-value 
Prescriber Demographics   
Female -0.21 0.21 0.33 -0.35 0.22 0.14 
Age (per 10 years) -0.17 0.10 0.09 -0.33 0.10 0.002 
Non-White Race (vs. White) 0.09 0.20 0.66 -0.41 0.21 0.07 
Assessment of Patients   
Assess illicit use of opioids 0.15 0.09 0.12 -0.10 0.10 0.32 
Inform patients about sources for sterile 
syringes -0.06 0.07 0.35 0.09 0.08 0.27 
Patient Substance Use   
Had a patient who overdosed on opioids   
Don't Know -0.82 0.32 0.02 -0.86 0.34 0.02 
Yes -0.57 0.31 0.08 -0.58 0.34 0.11 
No (reference) -- -- -- -- -- -- 
Prior Training    
Completed a buprenorphine course (Yes vs. 
No) 0.99 0.26 0.0003 -0.08 0.23 0.72 
Amount of naloxone training -- -- -- 0.19 0.09 0.03 
Attitudes and Beliefs   
Buprenorphine maintenance blocks effects of 
opioids 0.35 0.12 0.004 -- -- -- 
Buprenorphine reduces risk of dying 0.21 0.15 0.15 -- -- -- 
Naloxone reduces risk of dying -- -- -- 0.07 0.15 0.64 
Overdose must be handled by professionals -- -- -- -0.08 0.09 0.39 
Confidence in Prescribing (1-100 scale)   
Confidence in prescribing buprenorphine (per 
10 points) 0.14 0.03 < 0.001 -- -- -- 
Confidence in prescribing naloxone (per 10 
points) -- -- --   0.14 0.04 0.0006 
• Prescribers expressed moderate intention to prescribe 
buprenorphine (mean score= 2.9, SD=1.5) and naloxone (mean 
score=3.3, SD=1.4). 
• Positive correlates for bup  included: having completed a bup 
course (b=0.99, p=0.0003), agreeing that bup blocks the effects 
of opioids (b=0.35, p=0.004), and greater confidence in 
prescribing bup (b=0.14, p < 0.0001) 
• Negative correlates for bup:: Report they did not know whether 
they had a patient who overdosed on opioids (vs. “No”) (b=-0.82, 
p=0.02) 
• Positive correlates for naloxone included: greater amount of 
naloxone training (b=0.19, p=0.03) and greater confidence in 
prescribing naloxone (b=0.14, p=0.0006) 
• Negative correlates for naloxone: Age (per 10 years) (b=-0.33, 
p=0.002) and not knowing whether they had a patient who 
overdosed on opioids (b=-0.86, p=0.02) 
PTSL Overview 
• PTSL is an implementation intervention trial. Using a stepped 
wedge design, the intervention will test the implementation of 
evidence-based training, mentoring, technical support, and 
academic detailing to encourage HIV clinicians to adopt naloxone 
prescribing and office-based opioid treatment with buprenorphine.  
• PTSL leverages the value of ”saving lives” among HIV clinicians in 
a process to increase their motivation to deliver effective 
medications for opioid dependence. 
• Beginning with naloxone prescribing, the PTSL study utilizes 
academic detailing with motivational interviewing (MI) to encourage 
HIV clinicians to accept a larger role in treating the primary disease 
(opioid addiction) with office-based buprenorphine. 
Implementation Intervention 
• Implementation is being rolled out sequentially among HIV 
practices in three 6-month phases  
• The intervention includes (1) a 1.5-hour, onsite peer-to-peer 
training with continuing medical education credits provided that 
focuses on saving lives through naloxone prescribing and 
introduces the idea that office-based medication is available to 
treat the primary disease (opioid addiction) in their office;  (2) 
expert mentoring and technical support for the physicians and 
practice; (3)  academic detailing by a clinician trained in MI at 1, 3, 
and 5 months after the initial training; and (4) pharmacist peer-to-
peer outreach to local pharmacies to ensure that the medications 
are available.  
Outcomes 
• Primary outcomes: (1) Feasibility, acceptability, readiness and 
intent to prescribe naloxone and buprenorphine; (2) number of 
clinicians prescribing naloxone and Bup/Nx (i.e. uptake); (3) 
number of patients prescribed naloxone or Bup/Nx (i.e. 
penetration).  
• Secondary outcomes: (1) themes related to implementation 
facilitators and barriers in qualitative interviews; (2) the rate of 
physician statements that favor change in prescribing behavior in 
the audiotaped detailing sessions (e.g. change talk)  
Funding: National Institute on Drug Abuse (R01DA038082) 
Saved by the BAL: A Case of Eosinophilic Pneumonia after  
Methyl-Naltrexone Injection 
Anthony Esposito DO, Benison Lau MD 
UMass Medical School - Baystate Medical Center, Springfield, MA 
Introduction 
Eosinophilic pneumonia (EP) can be an adverse effect of 
many drugs, including methly-naltrexone. Methyl-
naltrexone injection has become increasingly popular, 
but its use does not come without risks.  
• Methyl-naltrexone is increasingly utilized as an 
effective treatment for alcohol dependence disorder. 
Its possible association with EP was initially noted in 
a large randomized control trial published in JAMA by 
Garbutt et al. 
 
• Imaging findings typically include bilateral reticular 





A 44-year-old male with history of alcohol use disorder 
was brought to the emergency department (ED) by 
ambulance in acute respiratory failure. He received his 
monthly naltrexone injection three days prior. The 
following day, he started having lip swelling, swollen 
ankles, severe headache, rash, and two days later, had 
dyspnea. Upon arrival to the ED, he was given two doses 
of IM epinephrine, as well as methylprednisolone 125 mg 
IV, and he required BiPAP, after what was thought to be 
an anaphylactic reaction to naltrexone.  
 
Chest x-ray revealed stable bilateral lower lobe 
opacities. CBC demonstrated increased absolute levels 
of eosinophils (700k/mm3), anaphylaxis was ruled out 
with tryptase level of 2.8 (normal <11.5) 
 
CTA of chest demonstrated no evidence of pulmonary 
embolism, but did reveal diffuse ground glass opacities 
consistent with acute infiltrates.  
 
Bronchoscopy with bronchoalveolar lavage (BAL) was 
performed and fluid from the BAL revealed  76 and 37 
white blood cells in the right and left fluid samples with 
eosinophils making up 50% and 53% of WBC 
respectively and fluid was negative for malignant cells.  
 
Eosinophilic pneumonia diagnosis was established and 
steroids were initiated with improvement. 
Conclusion 
This case demonstrates a likely outcome of eosinophilic 
pneumonia in a patient receiving methyl-naltrexone 
injections for alcohol use disorder. It is important to 
recognize naltrexone as a possible etiology for 
eosinophilic pneumonia due to its increasing use, 
likelihood of repeat exposure, and if missed with 
potential for subsequent harm.  
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Image 1: CTA imaging of chest revealed ground-glass opacities bilaterally more 
pronounced in the periphery 
Discussion 
• Acute eosinophic pneumonia is characterized by 
acute onset febrile illness, hypoxemia, diffuse bilateral 
infiltrates on imaging, and pulmonary eosinophilia 
with more than 25% eosinophils in BAL.  
 
• EP is characterized by symptoms lasting less than 1 
month and usually less than 1 week. EP will respond 
rapidly to steroid therapy but early recognition 
remains important to choose appropriate therapy 
given mimics such as infection.  
 
• Several medications have historically been shown to 
cause EP, in one review of the literature the most 
commonly cited drugs include antibiotics, such as 
daptomycin, minocycline and nitrofuration, or anti-
inflammatories, such as mesalamine and 
sulfasalazine.  
THE USE OF COGNITIVE SCREENING AS A PREDICTOR OF 
HOSPITALIZATION AND POST-HOSPITALIZATION OUTCOMES 
 
ALI SHAMI,MD; MAURA BRENNAN,MD; PETER ST. MARIE; MIHAELA S STEFAN, MD, PHD 
BACKGROUND 
• Prior studies  suggest that patients with cognitive impairment 
(CI) are at risk for worse post-hospitalization outcomes 
including hospital readmission and mortality. 
 
• The Mini-Cog test provides a quick bedside screening tool for 
cognitive impairment taking only a few minutes to administer. 
 
• Our aim was to determine whether CI as screened for by the 
Mini-Cog test early during hospitalization was associated with 
hospital readmission, length of stay and mortality. 
METHODS 
RESULTS 
• Prospective cohort study:  668 patients ≥ 65 years of age 
admitted to Baystate Medical Center over a two-year period.  
 
• Both medical and surgical inpatients were screened for CI 
with the Mini-Cog test within 24 hours of admission. 
 
• Demographic information, comorbidities, diagnoses, length of 
stay and readmission events were all collected.  
 
• One-year mortality data was obtained from the National 
Death Index.  
 
• We performed multivariable regression adjusting for 
confounders to determine association between CI and our 
outcomes. 
DISCUSSION 
• CI as detected by the Mini-Cog test was not associated with 
readmission, length of stay, or 1-year mortality. However, it 
was associated with the likelihood of discharge to nursing 
home.  
• Association between CI and post-hospitalization outcomes is 
likely complex with many effect modifiers and confounders.  
• Prior studies have focused on a specific population (e.g. 
orthopedic surgery patients). We included all patients.  
• Limitations: single center study; only English-speaking 
patients were included; and the level of home support may 
be a significant factor that is difficult to quantify. 
• Other tools such as frailty assessment may be more useful in 
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MINI-COG TEST [1] 
• Median age: 80 years (IQR 74-86). 
• Gender: 58% female. 
• 35% screened positive for CI. 
 
Those screening positive were (p<0.001 for all): 
• Older (median age 83 vs 78) 
• Had more prior hospitalizations 
• Less likely to be admitted from home  
• Of lower functional independence and self-reported 
performance scores.  
• More likely to be discharged to a post-acute care facility 
(54% vs 39%).  
 
    Cognitive  Screening   
  Total Negative Positive p 
N 668 436 232   
30 Day Readmission 
(%) 
101 (15.1) 63 (14.4) 38 (16.4) 0.58 
60 Day Readmission 
(%) 
167 (25.0) 100 (22.9) 67 ( 28.9) 0.11 
90 Day Readmission 
(%) 
197 (29.5) 116 (26.6) 81 (34.9) 0.03 
Length of Stay 
(median [IQR]) 





1 Year Survival (%) 545 (81.6) 367 ( 84.2) 178 (76.7) 0.02 
Discharge Home (%) 375 (56.1) 268 ( 61.5) 107 (46.1) <0.001 
  Unadjusted   Adjusted 
  Odds Ratio   95% CI   Odds 
Ratio 
  95% CI 
30-Day Readmission  1.16   0.75 1.80   1.02   0.64 1.64 
60-Day Readmission 1.33   0.92 1.92   1.18   0.79 1.75 
90-Day Readmission 1.46   1.02 2.08   1.39   0.94 2.06 
1-year survival 0.62   0.42 0.92   0.82   0.53 1.27 
FUNDING 
Supported by National Center for Research Resources (NCRR), National Institutes of Health (NIH) through the 
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Table 1. Unadjusted Outcomes Based on Cognitive Screening Result. 
Table 2. Adjusted Outcomes* Based on Cognitive Screening Result. 
*Adjusted for age, sex, race, admission source, Elixhauser score, Edmonton functional 
independence score and Edmonton self-reported performance score. 
Walk a day in my shoes  
Ryan Quarles, MD, Donald Kirton, MD, Reham 
Shaaban, DO, Kevin Hinchey, MD,  
Heather Z. Sankey, MD, MEd 
         
Nursing role on the healthcare team 
•   “We all have the same shared goal of doing best by our patients.” 
 
Appreciation of nursing clinical knowledge and skills 
• “Amazing how much they know” 
• “Nurses are empowered to make some decision on their own” 
 
Work load of nursing Staff 
• “I learned the time differential between the time that the nurse spends with 
the patient versus what the doctor spends with the patient. Doctor is in and 
out and [the nurses] are always with [the patients]” 
• “[Nurses] have to do a lot of charting.  Lots of and lots of documentation” 
• “Doctors have a way to get away, but nurses don’t. “  
 
Source of learning 
• “[The Nurse] knew everything about the patient, even about the patient’s 
lives” 
•    “[Nurses] are a huge resource and wealth of information “ 
 
Communication 
• “[Nurses] know a lot about the patient, you’d be at a huge disadvantage if 




• “They have our (physicians) back” 
Discussion: Barriers & Strategies  
Barriers 
•Recognition of the value of shadowing across the department.  
•Building this experience into protected orientation time is very 
important.  
 
Next Steps and Sustainability  
•Rework our structured debrief and debrief nurses and residents 
separately 
•Complete a pre-experience interview to understand pre-experience 
knowledge 
•Reassess practicality of surveying all residents on attitude 
 
METHODS: Interventions/Changes 
Incoming residents in IM, Peds and OB/GYN were scheduled to 
shadow floor nurses on their respective units. 
 
The shadowing sessions were developed to be 4 hours in length 
with nurses who volunteered for the experience. 
 
After each session, residents and nurses involved  were debriefed 
with a pre-determined set of questions as well as open discussion 
on observations , lessons learned and commitments with their 
program leadership as well as a nurse manager. 
INTRODUCTION: Background 
Provider burnout has been identified as a public health crisis and 
efforts to study and improve wellness are being undertaken by most 
major academic medical centers.  One of the strongest influences to 
improve prevent provider burnout and improve wellness is 
satisfaction at work and feeling appreciated.  The relationships we 
build at work can make or break our work environment and make a 
significant difference between dreading work and enjoying it.  When 
a provider dreads the work that they do and the environment they 
are in, then  having empathy for our patients and coworkers is 
affected.  
 
We believe we can improve empathy by building stronger 
relationships within the healthcare team through a shared 
understanding of our roles and how we can work better together 
through shadowing experiences. 
METHODS:  Measures/Metrics 
A semi-structured  debriefing  was recorded and transcribed for 
review. 
 
The transcribed debriefing is undergoing a qualitative analysis for 
themes identified with the group. 
NI VI  Meeting #4 Tucson, AZ  March 2019 
Aim/Purpose/Objectives 
• Assess the short and long term impact on empathy, 
understanding and communications  of existing Nurse-Resident 
shadowing experiences during orientation for our programs in 
Internal Medicine (IM), Pediatrics (Peds)  and Obstetrics And 
Gynecology (OB/GYN). 
• Expand the program to other residencies and programs to have 
residents shadowing each other across specialties. 
• Expand the shadowing experience to other healthcare 
students and residencies and even wider into the system as 
part of the system wide provider orientation. 
• Develop a program by which nurses can shadow residents and 
attendings to understand their workflow and structure. 
 
RESULTS: Themes Identified 
RESULTS 
22 incoming Internal Medicine and Med/Peds Residents shadowed 
floor nurses for a period of 4 hours starting with a nurse to nurse 
sign-out. 
 
There were separate debriefings  with each of the three groups 
immediately after the experience that included both residents and 
nurses 
 
Residents in Ob/Gyn were scheduled for a four-hour shadowing 
with volunteer nurses, but a misunderstanding by staff caused the 
residents to shadow senior residents for 4 hours instead. 
•Resident physicians are unaware of the level of involvement and 
expertise nurses have in the care of their patients 
 
• Experiencing the  work flow and demands of a nurse’s day place  
on the team creates deeper understanding and appreciation for 
their role on the team. 
 
Key Findings 
